Premium
Antiangiogenic therapy combined with TACE – more beneficial therapeutic effect in HCC
Author(s) -
Wang Z.,
Li Z.
Publication year - 2010
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2010.04289.x
Subject(s) - medicine , thalidomide , hepatocellular carcinoma , placebo , randomized controlled trial , gastroenterology , adverse effect , combination therapy , transcatheter arterial chemoembolization , therapeutic effect , surgery , pathology , alternative medicine , multiple myeloma